hit counter
Bio-Rad Laboratories, Inc. (BIO) Stock News Sentiment & Price - Sentifly
BIO - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Bio-Rad Laboratories, Inc. (BIO)

USA
Medical Laboratories & Research
NYSE
BIO Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BIO Latest news
Zacks Investment Research
Positive
Recent Price Trend in Bio-Rad (BIO) is Your Friend, Here's Why
2021-11-04 09:57

If you are looking for stocks that are well positioned to maintain their recent uptrend, Bio-Rad (BIO) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Investment Research
Positive
Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised
2021-10-29 12:14

Strength in the Life Science and Clinical Diagnostics segments drove Bio-Rad's (BIO) revenues in the third quarter.

Seeking Alpha
Neutral
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2021 Results - Earnings Call Transcript
2021-10-28 21:53

Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
Bio-Rad Laboratories (BIO) Surpasses Q3 Earnings and Revenue Estimates
2021-10-28 19:06

Bio-Rad (BIO) delivered earnings and revenue surprises of 61.30% and 11.33%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Business Wire
Neutral
Bio-Rad Reports Third-Quarter 2021 Financial Results
2021-10-28 16:15

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the third quarter ended September 30, 2021. Third-quarter 2021 net sales were $747.0 million, an increase of 15.4 percent compared to $647.3 million reported for the third quarter of 2020. On a currency-neutral basis, quarterly sales increased 13.8 percent compared to the same period in 2020. Third-qu

InvestorPlace
Neutral
9 Moonshot Bets to Beat Hedge Funds at Their Own Game
2021-10-22 16:59

Beating the market is hard, but it can be made easier by using the right set of tools. Here are the metrics to analyze penny stocks.

Zacks Investment Research
Positive
Bio-Rad (BIO) to Report Q3 Earnings: What's in the Cards?
2021-10-22 12:49

Recovery in Clinical Diagnostics arm and strong growth in Droplet Digital PCR platform are expected to have contributed to Bio-Rad's (BIO) Q3 results.

Forbes
Positive
Which Stocks Are More Attractive Than eBay's Stock?
2021-10-22 05:00

We believe that there are other stocks that are currently better valued than eBay's stock. EBAY's current price-to-operating income ratio (P/EBIT) of 16.7x is higher than levels of 13.3x for PerkinElmer, 10.7x for AGCO, 6.27x for Dish Network, 5.45x for Lennar and 5.45x for Bio-Rad Laboratories.

Zacks Investment Research
Negative
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
2021-10-21 17:24

Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research
Positive
Here's Why You Should Retain Bio-Rad (BIO) Stock For Now
2021-10-20 11:40

Investors are optimistic about Bio-Rad (BIO) on solid international market performance and raised 2021 guidance.

Loading more news...